Publications
Abstracts and Presentations (1104 POSTS)
2024 (63 POSTS)
Exploring the effects of toxic road runoff contaminants on juvenile salmonids with LC-MS/MS based metabolomics
Fender CL, Jackson M, Harper S, Jaramillo-Garcia M. Exploring the effects of toxic road runoff contaminants on juvenile salmonids with LC-MS/MS based metabolomics. Platform presentation at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, 2024.
Introduction: Challenges associated with the use of epidemiologic studies in chemical risk assessments
Schaefer H. Introduction: Challenges associated with the use of epidemiologic studies in chemical risk assessments. Abstract 1295, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, 2024.
View AbstractCapturing unknowns: Increasing utility of epidemiologic studies as key evidence in chemical risk assessment
Schaefer H. Capturing unknowns: Increasing utility of epidemiologic studies as key evidence in chemical risk assessment. Abstract 1294, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, 2024.
View AbstractAOP Network: Disruption of sonic hedgehog leading to orofacial clefts
Reynolds JI, Johnson B. AOP Network: Disruption of sonic hedgehog leading to orofacial clefts. Abstract 3625, Society of Toxicology 63rd Annual Meeting, Salt Lake City, 2024.
View AbstractStudy quality evaluation of literature reporting plastic microparticle exposure against reproductive and developmental toxicity endpoints
Fitch S, Ellis-Hutchings R, Rogers J, Marty S, Rushton E,… Wikoff D. Study quality evaluation of literature reporting plastic microparticle exposure against reproductive and developmental toxicity endpoints. Abstract 5159, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractIntegration of toxicological and epidemiological information to evaluate biological plausibility and causality of associations between inhaled formaldehyde (FA) and lymphohematopoietic (LHP) cancers
Vincent M, Fitch S, Bylsma L, Thompson C, Rogers S, Britt J, Wikoff D. Integration of toxicological and epidemiological information to evaluate biological plausibility and causality of associations between inhaled formaldehyde (FA) and lymphohematopoietic (LHP) cancers. Abstract 5157, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractDioxin-like compounds in soils: A pilot survey updating background soil TEQ
Urban JD, Covington TR, Fitch SE, Wikoff DS. Dioxin-like compounds in soils: A pilot survey updating background soil TEQ. Abstract 5147, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractDerivation of manganese 24-hour acute inhalation guideline protective of respiratory and neurological effects
Perry CS, Vivanco SN, Verwiel AH, Proctor DM. Derivation of manganese 24-hour acute inhalation guideline protective of respiratory and neurological effects. Abstract 4751, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractOptimizing androgen receptor prioritization using high-throughput assay-based activity models
Edwards S, Antonijevic T, Nelms M, Ring C, Harris D,… Borghoff S, Markey K. Optimizing androgen receptor prioritization using high-throughput assay-based activity models. Abstract 4381, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractChemistry domain of applicability evaluation of estrogen receptor high-throughput assay-based activity models
Nelms M, Antonijevic T, Ring C, Harris D, Bever RJ,… Borghoff S, et al. Chemistry domain of applicability evaluation of estrogen receptor high-throughput assay-based activity models. Abstract 4380, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractDevelopment and application of systematic approach to inventory and interrogate thyroid hormone network information
Lynn SG, Lea IA, Urban J, Borghoff SJ, Wikoff D, Fitch S, Perry C, Choksi N, Britt J, Heintz M, Klaren W, et al. Development and application of systematic approach to inventory and interrogate thyroid hormone network information. Abstract 4357, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractEvaluation of the endocrine disrupting potential of di-isononyl phthalate
Borghoff SJ, Feifarek D, Mihalchik A, Heintz M, Haws L, Nyambego H, Goyak K, Lea IA. Evaluation of the endocrine disrupting potential of di-isononyl phthalate. Abstract 3931, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractEvaluation of the endocrine disrupting potential of di-isodecyl phthalate
Lea IA, Feifarek D, Mihalchik A, Heintz M, Haws L, Nyambego H, Goyak K, Borghoff SJ. Evaluation of the endocrine disrupting potential of di-isodecyl phthalate. Abstract 3930, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractLung cancer risk and exposure to hexavalent chromium: Results of extended mortality study of workers with low level exposures and quantitative risk assessment using pooled analysis of three cohorts
Allen B, Vincent M, Lipworth L, Panko J, Suh M, Jiang X, Mumma MT, Proctor D. Lung cancer risk and exposure to hexavalent chromium: Results of extended mortality study of workers with low level exposures and quantitative risk assessment using pooled analysis of three cohorts. Poster presentation at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
Evidence identification and appraisal supporting development of an updated toxicity value for HFPO-DA
Thompson CM, Heintz MM, Rogers SI, Fitch SE, Rivera BN, Klaren WD, Vincent MJ, Wikoff DS, Haws LC. Evidence identification and appraisal supporting development of an updated toxicity value for HFPO-DA. Abstract 3654, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractDelayed transcriptomic responses in PPARa knockout mouse hepatocytes compared to wild-type hepatocytes exposed to HFPO-DA or PPARa agonist GW7647: Support for a PPARa-dependent mode of action for HFPO-DA in mouse hepatocytes
Heintz M, Klaren W, East A, Haws L, Thompson C. Delayed transcriptomic responses in PPARa knockout mouse hepatocytes compared to wild-type hepatocytes exposed to HFPO-DA or PPARa agonist GW7647: Support for a PPARa-dependent mode of action for HFPO-DA in mouse hepatocytes. Abstract 4100, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractThe 2022 WHO reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls
DeVito, Bokkers B, van Duursen M, van Ede K, Feeley M,… Haws L,… Wikoff D, et al. The 2022 WHO reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls. Abstract 3626, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractNonclinical safety evaluation of 1-monoacetin and 2-monoacetin as potential impurities in pharmaceutical excipients
Petrick J, Mihalchik A, Tiwary A, Kreidl L, Swartz C, Bhattarai N. Nonclinical safety evaluation of 1-monoacetin and 2-monoacetin as potential impurities in pharmaceutical excipients. Abstract 3107, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractAssessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease
Franke K, Vincent M, Rogers S, Rivera B, Wikoff D. Assessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease. Abstract 3393, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View AbstractA meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness
Yoshino T, Hooda N, Younan D, Shitara K, Heinemann V,… Suh M, Reichert H, et al. 2023. 127P A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness. Ann Oncol 34(Suppl 4):S1519 [abstract]; doi :10.1016/j.annonc.2023.10.262.
View Abstract